Get the Stockscreener App
5.525
5.56%
-0.325
After Hours:
5.60
0.075
+1.36%
Profound Medical Corp stock is traded at $5.525, with a volume of 46,550.
It is down -5.56% in the last 24 hours and down -20.27% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$5.85
Open:
$5.84
24h Volume:
46,550
Relative Volume:
0.64
Market Cap:
$175.73M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-4.1231
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
-15.00%
1M Performance:
-20.27%
6M Performance:
-32.29%
1Y Performance:
-34.30%
1-Day Range:
$5.45
$5.9091
1-Week Range:
$4.75
$6.69
52-Week Range:
$4.75
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.525 | 175.73M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
131.93 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical Corp. (PROF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
(PROF) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
(PRN) Stock Evaluation Report (PRN:CA) - news.stocktradersdaily.com
Waterstone Impact Fund, Tim Tebow, Partner With eFuse - The Esports Advocate
Bronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medical Corp. (PROF) And Encourages Investors to Connect - markets.businessinsider.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Methanex CorporationMEOH - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Profound Medical Corp. (PROF) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
Profound Medical stock hits 52-week low at $5.62 amid market challenges By Investing.com - Investing.com South Africa
Profound Medical stock hits 52-week low at $5.62 amid market challenges - Investing.com Australia
Wolf Haldenstein Adler Freeman & Herz LLP is investigating - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws - GlobeNewswire Inc.
Profound Medical to Host Investor Event at AUA 2025 - TipRanks
Save the Date: Profound Medical to Host Investor Event at AUA 2025 - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medical Corp. (PROF) And Encourages Stockholders to Connect - ACCESS Newswire
iCAD, RamSoft to Deliver ProFound AI-Powered Mammography Solutions - Medical Product Outsourcing
Raymond James Financial Inc. Takes $7.46 Million Position in Piper Sandler Companies (NYSE:PIPR) - The AM Reporter
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm - Business Wire
Chairman of the Board & CEO of Profound Medical Picks Up 2.6% More Stock - simplywall.st
Insider Spends US$144k Buying More Shares In Profound Medical - Yahoo Finance
Public market insider buying at Profound Medical (PRN) - The Globe and Mail
(PRN) Investment Performance Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp. (NASDAQ:PROF) Sees Large Growth in Short Interest - Defense World
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - Stock Traders Daily
Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - Business Wire
How To Trade (PROF) - Stock Traders Daily
(PRN) Dynamic Trading Report (PRN:CA) - Stock Traders Daily
Profound Medical revises financials, corrects revenue overstatement By Investing.com - Investing.com South Africa
Profound Medical Corp. (NASDAQ:PROF) Q4 2024 Earnings Call Transcript - Insider Monkey
Profound Medical revises financials, corrects revenue overstatement - Investing.com
Profound Medical Q4 2024 revenue jumps 108% to USD 4.2M - Medical Buyer
Stifel maintains Buy on Profound Medical, $12 target post-Q4 results - Investing.com Canada
Profound Medical Corp. (PROF) reports earnings - Quartz
Profound Medical Corp. SEC 10-K Report - TradingView
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: R - GuruFocus.com
Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ... - Yahoo Finance
Profound Medical stock hits 52-week low at $6.61 amid market challenges - MSN
Profound Medical Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Profound Medical Q4 2024 beats EPS forecast By Investing.com - Investing.com UK
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: Profound Medical Q4 2024 beats EPS forecast - Investing.com
Profound Medical Corp. Q4 Income Retreats, But Beats Estimates - Nasdaq
iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America - Yahoo Finance
What To Expect From Profound Medical Corp (TSX:PRN) Q4 2024 Earnings - GuruFocus.com
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):